Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
E-Home Household Services Holdings Limited's subsidiary Zhongrun Pharmaceutical and New Zealand's NBL Pharmaceuticals Sign Cooperation Agreement to Expand International Markets

In This Article:

FUZHOU, China, Sept. 12, 2024 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, announced today that after the detailed business and market due diligence conducted by the Company and the detailed business and market due diligence conducted by New Zealand's NBL Pharmaceuticals (New Zealand) Limited ("NBL Corp.") from February 2024 to the present, the Company's subsidiary, Zhongrun (Fujian) Pharmaceutical Co., Ltd. intends to merge with NBL Pharmaceuticals of New Zealand in December this year, and the two parties have signed a cooperation agreement to expand the overseas market and improve the overall competitiveness of the Company before the formal merger is completed.

NBL Pharmaceuticals (New Zealand) Limited is located in Auckland, New Zealand, with advanced fully automated production lines. In order to meet the clean requirements of different production workshops, and to ensure the low temperature and low humidity requirements of special production processes, all the workshops comply with the dust-free standards of international ISO, New Zealand GMP, GB, and the GMP level 100,000 class dust-free workshop, which is in line with the international GMP standards for the construction of the workshop, with the total area of the factory covering more than 5,000 square meters, and the area of purification workshop exceeding more than 2,200 square meters. The three main production workshops are equipped with independent purification air-conditioning system, 10 sets of independent HVAC system, mainly producing powder and softgel capsules of fish oil, vitamins, anti-aging and other health care drugs.

Mr. Wenshan Xie, Chairman and CEO of E-Home, commented: "The signing of the cooperation agreement between E-Home's subsidiary, Zhongrun (Fujian) Pharmaceutical Co., Ltd. and NBL Pharmaceuticals (New Zealand) Limited is the result of E-Home's response to the company's overseas strategic layout based on the company's strategic development needs. layout, bringing numerous business opportunities for the company and further deepening the exchange and cooperation with overseas markets. The combination of Zhongrun (Fujian) Pharmaceutical Co., Ltd. and NBL Corp. can create a scaled healthcare drug portfolio and fist products, building a good complementary and synergistic advantage of Chinese and international resources. After half a year of market research, the company signed a cooperation agreement with NBL Corp. of New Zealand. The signing of this agreement is an important decision in the development of the company, which is in line with the company's long-term planning and internationalization strategy layout needs, and is conducive to help the company establish a wider range of partnerships globally and enhance the influence of the company's brand. In the future, the Company will continue to maintain joint development with global partners, provide better quality products and services for global users, and fully promote the implementation of this strategic decision."